Seigla Medical, founded in Buffalo, Minnesota, is a US-based startup dedicated to manufacturing innovative medical devices. The company's core mission is to enhance the efficacy and safety of complex percutaneous coronary interventions (PCI) through advanced radial access technology. Seigla's flagship product features an 18% larger lumen and a 45% thinner wall compared to traditional devices, aiming to improve patient outcomes and procedural efficiency. Their market focus is on healthcare providers specializing in interventional cardiology.

Notable affiliated individuals and investors include experienced professionals in the medical device industry, though specific names are not provided. Key achievements for Seigla Medical include the development of their groundbreaking radial access device, which has the potential to revolutionize PCI procedures by eliminating the need for femoral access conversion. The overall impact of Seigla Medical lies in its commitment to advancing medical technology and improving patient care in the field of interventional cardiology.